Literature DB >> 9989735

Deep-vein thrombosis.

A W Lensing1, P Prandoni, M H Prins, H R Büller.   

Abstract

Deep-vein thrombosis is an important complication of several inherited and acquired disorders, but may also occur spontaneously. Prevention of recurrent venous thrombosis and pulmonary embolism is the main reason for accurate diagnosis and adequate treatment. This seminar discusses only symptomatic deep-vein thrombosis. The diagnosis can be confirmed by objective tests in only about 30% of patients with symptoms. Venous thromboembolic complications happen in less than 1% of untreated patients in whom the presence of venous thrombosis is rejected on the basis of serial ultrasonography or ultrasonography plus either D-dimer or clinical score. Initial anticoagulant treatment (intravenous or subcutaneous heparin) should continue until oral anticoagulant treatment, started concurrently, increases the international normalised ratio above 2.0 for more than 24 h. The optimum duration of oral anticoagulant treatment is unresolved, but may be guided by the presence of temporary or persistent risk factors or presentation with recurrent venous thromboembolism.

Entities:  

Mesh:

Year:  1999        PMID: 9989735     DOI: 10.1016/s0140-6736(98)04298-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  23 in total

Review 1.  Suspected deep vein thrombosis: a management algorithm for the accident and emergency department.

Authors:  S Nawaz; P Chan; S Ireland
Journal:  J Accid Emerg Med       Date:  1999-11

2.  Deep vein thrombosis.

Authors:  H Schubert
Journal:  Can Fam Physician       Date:  2001-01       Impact factor: 3.275

3.  Eligibility for home treatment of deep vein thrombosis: prospective study.

Authors:  T Schwarz; B Schmidt; U Höhlein; J Beyer; H E Schröder; S M Schellong
Journal:  BMJ       Date:  2001-05-19

Review 4.  Acute pulmonary embolism. Part 1: epidemiology and diagnosis.

Authors:  Renée A Douma; Pieter W Kamphuisen; Harry R Büller
Journal:  Nat Rev Cardiol       Date:  2010-07-20       Impact factor: 32.419

5.  Identification of DVT diseases using numerical simulations.

Authors:  M Simão; J M Ferreira; J Mora-Rodriguez; H M Ramos
Journal:  Med Biol Eng Comput       Date:  2016-01-16       Impact factor: 2.602

Review 6.  New anticoagulants: beyond heparin, low-molecular-weight heparin and warfarin.

Authors:  Shannon M Bates; Jeffrey I Weitz
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

7.  Finding the origin of pulmonary emboli with a total-body magnetic resonance direct thrombus imaging technique.

Authors:  Kirsten van Langevelde; Alexandr Srámek; Patrice W J Vincken; Jan-Kees van Rooden; Frits R Rosendaal; Suzanne C Cannegieter
Journal:  Haematologica       Date:  2012-07-16       Impact factor: 9.941

8.  Multiple Venous Thromboses Presenting as Mechanical Low Back Pain in an 18-Year-Old Woman.

Authors:  Andrée-Anne Marchand; Jean-Alexandre Boucher; Julie O'Shaughnessy
Journal:  J Chiropr Med       Date:  2015-06-30

9.  Cost effectiveness of tinzaparin sodium versus unfractionated heparin in the treatment of proximal deep vein thrombosis.

Authors:  J Jaime Caro; Denis Getsios; Ingrid Caro; Judith A O'Brien
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

10.  A diagnostic strategy for pulmonary embolism based on standardised pretest probability and perfusion lung scanning: a management study.

Authors:  Massimo Miniati; Simonetta Monti; Carolina Bauleo; Elvio Scoscia; Lucia Tonelli; Alba Dainelli; Giosuè Catapano; Bruno Formichi; Giorgio Di Ricco; Renato Prediletto; Laura Carrozzi; Carlo Marini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-09-23       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.